Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays

We compared the accuracy of microarray measurements obtained with oligonucleotide arrays (GeneChip, Affymetrix) with a laboratory-developed cDNA array by assaying test RNA samples from an experiment using a paradigm known to regulate many genes measured on both arrays. We selected 47 genes represent...

Full description

Saved in:
Bibliographic Details
Published inNucleic acids research Vol. 30; no. 10; p. e48
Main Authors Yuen, Tony, Wurmbach, Elisa, Pfeffer, Robert L., Ebersole, Barbara J., Sealfon, Stuart C.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 15.05.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We compared the accuracy of microarray measurements obtained with oligonucleotide arrays (GeneChip, Affymetrix) with a laboratory-developed cDNA array by assaying test RNA samples from an experiment using a paradigm known to regulate many genes measured on both arrays. We selected 47 genes represented on both arrays, including both known regulated and unregulated transcripts, and established reference relative expression measurements for these genes in the test RNA samples using quantitative reverse transcriptase real-time PCR (QRTPCR) assays. The validity of the reproducible (average coefficient of variation = 11.8%) QRTPCR measurements were established through application of a new mathematical model. The performance of both array platforms in identifying regulated and non-regulated genes was identical. With either platform, 16 of 17 definitely regulated genes were correctly identified, and no definitely unregulated transcript was falsely identified as regulated. Accuracy of the fold-change measurements obtained with each platform was assessed by determining measurement bias. Both platforms consistently underestimate the relative changes in mRNA expression between experimental and control samples. The bias observed with cDNA arrays was predictable for fold-changes <250-fold by QRTPCR and could be corrected by the calibration function Fc = Fa(cDNA)q, where Fa(cDNA) is the microarray-determined fold-change comparing experimental with control samples, q is the correction factor and Fc is the calibrated value. The bias observed with the commercial oligonucleotide arrays was less predictable and calibration was unfeasible. Following calibration, fold-change measurements generated by custom cDNA arrays were more accurate than those obtained by commercial oligonucleotide arrays. Our study demonstrates systematic bias of microarray measurements and identifies a calibration function that improves the accuracy of cDNA array data.
Bibliography:istex:F6D70A8804C9ABB2F4FF6A11280E92C8081E352C
ark:/67375/HXZ-GFLNC4GX-P
local:gnf047
Received November 8, 2001; Revised March 10, 2002; Accepted March 23, 2002.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
To whom correspondence should be addressed at: Neurology Box 1137, Mount Sinai School of Medicine, New York, NY 10029, USA. Tel: +1 212 241 7075; Fax: +1 212 289 4107; Email: stuart.sealfon@mssm.edu The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
ISSN:0305-1048
1362-4962
1362-4962
DOI:10.1093/nar/30.10.e48